{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:36:03Z","timestamp":1792254963676,"version":"4.4.0"},"reference-count":14,"publisher":"Informa UK Limited","issue":"16","funder":[{"DOI":"10.13039\/100019450","name":"Verastem Oncology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100019450","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.2217\/fon-2021-1582","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T10:38:59Z","timestamp":1647254339000},"page":"1907-1915","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":26,"title":["Single Agent VS-6766 or VS-6766 Plus Defactinib in\n            <i>KRAS<\/i>\n            -Mutant Non-Small-Cell Lung Cancer: The RAMP-202 Phase II Trial"],"prefix":"10.1080","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2070-9335","authenticated-orcid":false,"given":"Enrica","family":"Capelletto","sequence":"first","affiliation":[{"name":"Department of Oncology, University of Turin,\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bironzo","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin,\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Denis","sequence":"additional","affiliation":[{"name":"Verastem Oncology \u2013 Chief Medical Officer,\rNeedham, \rMA, \rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Koustenis","sequence":"additional","affiliation":[{"name":"Verastem Oncology,\rNeedham, \rMA, \rUSA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maristella","family":"Bungaro","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin,\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Novello","sequence":"additional","affiliation":[{"name":"Department of Oncology, University of Turin,\rItaly"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,3,14]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4389"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.01.015"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2020.06.023"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.06.001"},{"key":"e_1_3_5_7_1","unstructured":"ClinicalTrials.gov . A study of VS-6766 v. VS-6766 + Defactinib in recurrent G12V other KRAS and BRAF non-small cell lung cancer (RAMP202) (2022). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04620330?intr=VS-6766&phase=1&draw=2&rank=2"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.47327"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt210"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-1244-2"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2020-CT143"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.AM2021-CT019"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2008.10.026"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2019.10.033"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy275"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.03022"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon-2021-1582","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:46:03Z","timestamp":1719125163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon-2021-1582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,14]]},"references-count":14,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.2217\/fon-2021-1582"],"URL":"https:\/\/doi.org\/10.2217\/fon-2021-1582","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-12-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-03-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}